Direct oral anticoagulants vs warfarin in patients with inflammatory bowel disease and atrial fibrillation: a comparative analysis of efficacy and safety
Introduction: Patients with inflammatory bowel disease (IBD) and atrial fibrillation (AF) are at increased risk for thromboembolic events and require anticoagulation therapy.1,2 However, the choice between direct oral anticoagulants (DOACs) and warfarin remains a subject of debate because of potenti...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Clinical Medicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1470211825001010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|